
FDA Approves Generic Lenacapavir for HIV, but Brazil Is Left Out of Cheap Distribution
The highly effective twice-yearly injection will reach 120 countries at US$ 40 per person per year; in Brazil, the maximum authorized price is R$ 20,900 per dose.
Brazil and the world in perspective.
English edition. Stories are translated from the Portuguese original; any story not yet translated is shown in Portuguese.
Public health, medicine and wellbeing.
10 stories
The highly effective twice-yearly injection will reach 120 countries at US$ 40 per person per year; in Brazil, the maximum authorized price is R$ 20,900 per dose.
The state records its first death from the disease in more than 30 years; the country has 4,852 cases this year, double the 2025 total.
Research in Nature Medicine analyzed 204 countries; for Brazil, the estimate points to 26,500 cases and 10,900 deaths in 2023.
The result with lorlatinib is unprecedented in advanced disease, but the drug costs about R$ 37,000 a month and is not covered by the SUS.
INSS granted 377 benefits for gambling disorder through August; experts say the real number is higher because of underreporting.
The new registrations are for liraglutide and semaglutide, but there is still no launch date or set pharmacy price.
Sisvan records 11.12 million adults with obesity in 2026; 71.5% of those monitored are above their ideal weight.
State Health Department confirms 211 cases in 2026, compared with 119 last year, with no deaths recorded; the capital accounts for 167.
The family of a 14-year-old goalkeeper donated organs and helped bring the issue to light; São Paulo has 23,700 patients waiting.
Health Ministry dashboard shows 52.45% coverage of the target group in the South, Southeast, Center-West and Northeast; experts cite El Niño.